Search
Activity Based Funding Conference
Event
In May 2022 health professionals from around Australia and across the world came together for the ninth Activity Based Funding Conference series. 47 people who shared their research and insights to drive improvements in the delivery of healthcare services.
Aged Care Pricing Commissioner Annual Report 2020-21
Resource
The Annual Report of the Aged Care Pricing Commissioner covers the Commissioner’s operations for the year 1 July 2020 to 30 June 2021 in accordance with Section 95B-12 of the Aged Care Act 1997.
Management of Confidential Jurisdictional Information Protocol
Resource
The Management of Confidential Jurisdictional Information Protocol outlines the limited and prescribed purpose for which the Independent Health and Aged Care Pricing Authority can collect and analyse confidential jurisdictional information and the processes and controls in place to prevent unauthorised access and disclosure to unauthorised parties.
IHPA Annual Report 2020–21
Resource
Independent Hospital Pricing Authority (IHPA) Annual Report for financial year 2020–21.
Methodology for Determining the Benchmark Price for Prostheses in Australian Public Hospitals
Resource
The Independent Hospital Pricing Authority’s (IHPA) primary function is to calculate and deliver an annual national efficient price (NEP). The NEP is a major determinant of the level of Australian Government funding for public hospital services and provides a price signal or benchmark for the efficient cost of providing public hospital services. The 2021–22 Federal Budget, released in May 2021, included a measure to modernise and improve the private health insurance Prostheses List. This measure will better align the price set for medical devices on the Prostheses List for private providers with those paid for in competitive markets, such as the public hospital system. IHPA has been requested to establish the benchmark price that is paid for prostheses in the public sector, in order that the gap between the public sector benchmark price and the prices (also referred to as Prostheses List benefits) currently mandated on the Prostheses List can be determined. IHPA released a Consultation Paper on a Methodology for Determining the Benchmark Price for Prostheses in Australian Public Hospitals (the Consultation Paper) on 6 September 2021. The Consultation Paper sought feedback on the key issues to assist IHPA in preparing the report to the Commonwealth Department of Health regarding the benchmark price for prostheses in the public sector.
Australian Hospital Patient Costing Standards Version 4.1
Resource
The Australian Hospital Patient Costing Standards (AHPCS) provide direction for hospital patient costing through the development of standards for specific elements of the costing process and reporting requirements.
Pricing and Funding for Safety and Quality: Sentinel Events Fact Sheet
Resource
In 2017, all Australian governments signed the Addendum to the National Health Reform Agreement and committed to improve Australian health outcomes through safety and quality reforms.
Indexed list of agency files - 1 July to 31 December 2021
Resource
Mental Health Phase of Care Clinical Refinement Testing Project – Final Report
Resource
The Mental Health Phase of Care (MHPoC) Clinical Refinement Testing Project aimed to determine whether refinements to the MHPoC recommended as part of the 2017 Clinical Refinement Project improved the reliability of how MHPoC definitions are applied by clinicians. This report outlines the findings from the testing and recommendations on the future refinement of the MHPoC. This report was approved by the Pricing Authority in May 2021.
Senate Order on Departmental and Agency Contracts Period 1 July 2020 to 30 June 2021
Resource
Indexed list of agency files - 1 January to 30 June 2021
Resource
IHPA Work Program and Corporate Plan 2021–22
Resource
The Independent Hospital and Pricing Authority (IHPA) Work Program and Corporate Plan 2021–22 has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011 and section 35(1)(b) of the Public Governance, Performance and Accountability Act 2013 for the reporting periods 2021–22 to 2023–24.